Coherus Biosciences(DE:8C5)
€0.45-0.02 (-3.21%)
DE:8C5
Coherus Biosciences earnings date
€0.45
At close:-0.02 (-3.21%)
Coherus Biosciences (8C5) Q2 2026 Earnings Report
2 Followers
DE:8C5 Q2 2026 EPS Results
- Actual EPS
- -EUR 0.20
- Consensus EPS
- -EUR 0.23
- Beat/Miss
- Beat by +EUR 0.03
- One Year Ago EPS
- -EUR 0.35
DE:8C5 Q2 2026 Revenue Results
- Actual Revenue
- EUR 13.02M
- Expected Revenue
- EUR 13.11M
- Beat/Miss
- Missed by -EUR 90.06K
- YoY Revenue Growth
- +39.53%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/05/2026
- Time
- During Market Hours
- Conference Call
- Wednesday, August 5, 2026
DE:8C5 Upcoming Earnings
Coherus Biosciences's next earnings date is estimated for March 15, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
DE:8C5 Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:8C5 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 15, 2027 | 2026 (Q4) | -0.18- | -0.35 | ― | ― |
| Nov 09, 2026 | 2026 (Q3) | -0.20-0.23 | -0.28 | 19.35% (+0.05) | |
| Aug 05, 2026 | 2026 (Q2) | -0.23-0.20 | -0.35 | 43.59% (+0.15) | |
| May 11, 2026 | 2026 (Q1) | -0.20-0.25 | -0.37 | 34.15% (+0.13) | |
| Mar 09, 2026 | 2025 (Q4) | -0.32-0.35 | -0.4 | 11.36% (+0.05) | |
| Nov 06, 2025 | 2025 (Q3) | -0.32-0.28 | -0.08 | -244.44% (-0.20) | |
| Aug 07, 2025 | 2025 (Q2) | -0.20-0.35 | -0.1 | -254.55% (-0.25) | |
| May 12, 2025 | 2025 (Q1) | -0.27-0.37 | 0.76 | -149.40% (-1.13) | |
| Mar 10, 2025 | 2024 (Q4) | -0.28-0.40 | -0.65 | 38.03% (+0.25) | |
| Nov 06, 2024 | 2024 (Q3) | -0.15-0.08 | -0.37 | 78.05% (+0.29) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

